Insider trading of G Walter Ii Loewenbaum, a Director at DDD 3D Systems Corporation
Most recently G Walter Ii Loewenbaum bought 1,000 shares worth $9,330.00 on 6 December 2017.
|Shares||Price per share||Total price||Shares after||Source|
|2017-12-06||DDD||G Walter Ii Loewenbaum||Director||Buy||1,000||$9.33||$9,330.00||1,069,707||SEC insider form 4|
|2017-12-05||DDD||G Walter Ii Loewenbaum||Director||Buy||15,000||$9.37||$140,550.00||1,068,707||SEC insider form 4|
|2017-12-04||DDD||G Walter Ii Loewenbaum||Director||Buy||40,500||$8.94||$362,070.00||1,053,707||SEC insider form 4|
|2017-12-01||DDD||G Walter Ii Loewenbaum||Director||Buy||6,430||$8.81||$56,648.30||1,013,207||SEC insider form 4|
|2017-05-30||DDD||G Walter Ii Loewenbaum||Director||Sale||25,000||$21.50||$537,500.00||982,106||SEC insider form 4|
|2017-05-23||DDD||G Walter Ii Loewenbaum||Director||Sale||25,000||$22.29||$557,250.00||1,007,106||SEC insider form 4|
|2017-05-18||DDD||G Walter Ii Loewenbaum||Director||Sale||25,000||$22.15||$553,750.00||1,032,106||SEC insider form 4|
|2016-05-12||DDD||G Walter Ii Loewenbaum||Director||Buy||20,000||$12.08||$241,600.00||1,014,810||SEC insider form 4|
About 3D Systems Corporation
3D Systems Corporation, through its subsidiaries, provides 3D printing products and services worldwide. The companys 3D printers transform data input generated by 3D design software, CAD software, or other 3D design tools into printed parts using a range of print materials, including plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and Class IV bio-compatible materials. It offers various 3D printing technologies, such as stereolithography, selective laser sintering, direct metal printing, multijet printing, and colorjet printing. The company also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and Class IV bio-compatible materials. It offers its printers under the Accura, DuraForm, LaserForm, CastForm, and VisiJet brand names. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as products for product design, mold and die design, 3D scan-to-print, reverse engineering, and production machining and inspection. Further, it offers proprietary software and drivers that provide part preparation, part placement, support placement, build platform management, and print queue management; and 3D virtual reality simulators and simulator modules for medical applications, as well as digitizing scanners for medical and mechanical applications. Additionally, the company provides warranty, maintenance, and training services; on-demand solutions; and software and healthcare services. It primarily serves companies and small and midsize businesses in a range of industries, including healthcare, automotive, aerospace, government, defense, technology, electronics, education, consumer goods, and energy. The company sells its products and services through direct sales force, partner channels, and distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
- 3D Systems Corporation, 333 Three D Systems Circle, Rock Hill 29730, United States
Insider trading of G Walter Ii Loewenbaum, a Director at LMNX Luminex Corporation
Most recently G Walter Ii Loewenbaum sold 50,000 shares worth $1,089,500.00 on 16 November 2017.
|Shares||Price per share||Total price||Shares after||Source|
|2017-11-16||LMNX||G Walter Ii Loewenbaum||Director||Sale||50,000||$21.79||$1,089,500.00||664,217||SEC insider form 4|
|2017-05-30||LMNX||G Walter Ii Loewenbaum||Director||Sale||25,000||$20.07||$501,750.00||713,896||SEC insider form 4|
|2017-05-23||LMNX||G Walter Ii Loewenbaum||Director||Sale||25,000||$20.23||$505,750.00||738,896||SEC insider form 4|
|2017-05-18||LMNX||G Walter Ii Loewenbaum||Director||Sale||25,000||$20.80||$520,000.00||763,753||SEC insider form 4|
|2017-01-26||LMNX||G Walter Ii Loewenbaum||Director||Sale||20,000||$19.75||$395,000.00||757,162||SEC insider form 4|
|2017-01-19||LMNX||G Walter Ii Loewenbaum||Director||Sale||20,000||$19.82||$396,400.00||777,162||SEC insider form 4|
|2017-01-12||LMNX||G Walter Ii Loewenbaum||Director||Sale||20,000||$20.43||$408,600.00||797,162||SEC insider form 4|
|2017-01-05||LMNX||G Walter Ii Loewenbaum||Director||Sale||20,000||$20.32||$406,400.00||817,162||SEC insider form 4|
|2016-12-29||LMNX||G Walter Ii Loewenbaum||Director||Sale||20,000||$20.27||$405,400.00||837,162||SEC insider form 4|
|2016-11-28||LMNX||G Walter Ii Loewenbaum||Director||Sale||50,000||$20.57||$1,028,500.00||749,414||SEC insider form 4|
About Luminex Corporation
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and life sciences industries worldwide. The companys products include Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; Verigene system, an automated multiplex-capable system; and ARIES system, a sample to answer real-time PCR platform. It also offers MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; ARIES cassettes that are self-contained assay consumables; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; respiratory viral family of products to identify the causative agent for respiratory infections; and gastrointestinal pathogen panel assays to identify the pathogens causing infectious gastroenteritis. In addition, the company offers MultiCode assays and products comprising HSV 1&2 assays, analyte specific reagents, and other products to detect infectious agents in clinical samples; ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, and ARIES GBS assays; Verigene test cartridges; cystic fibrosis family of products comprising IVD kits for cystic fibrosis genotyping; pharmacogenetics family of products consisting of assays to determine the drug metabolism status; and specialty product family and instrumentation products, as well as operates as an original equipment manufacturer of custom reagents and instrumentation. It serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
- Luminex Corporation, 12212 Technology Boulevard, Austin 78727, United States